Most adults do not need a routine measles booster
Renewed measles outbreaks have prompted a practical question for adults: is another vaccine dose needed? For most people, the answer is no. Experts cited by the Associated Press say that people who were vaccinated against measles as children, or who previously had the disease, are generally protected without an additional booster.
The issue has become more urgent as outbreaks have reversed public-health gains. The United States, Mexico and Bolivia lost their measles-free status this week, according to the report. Canada lost its measles-elimination designation last year. Those developments underscore the importance of confirming protection, especially for people whose records are incomplete or whose work brings them into close contact with patients.
Measles is among the world’s most contagious viral diseases. The standard protection is the measles, mumps and rubella vaccine, usually called MMR. The article notes that one dose is 93% effective at preventing measles and two doses are 97% protective.
What counts as evidence of immunity
Vaccination is not the only basis for protection. Having previously had measles is generally considered protective for life. In the United States, people born before 1957 are also considered to have presumptive evidence of immunity because measles was so widespread in childhood before vaccines became routine.

For adults with vaccination records, the key question is whether their prior doses meet current guidance. The report says adults are now recommended to have at least one documented MMR dose. Some people in higher-risk settings should have two doses unless they have another accepted form of evidence of immunity.
That does not mean every adult needs to seek an extra dose during an outbreak. Dr. Richard Martinello of Yale School of Medicine told the AP that most people are protected without a booster. The distinction matters: public-health attention can be focused on people most likely to be unprotected rather than treating an additional dose as a universal requirement.
Groups that should consider another dose
One group identified in the report is health-care workers born before 1957 who do not have proof of immunity. Although birth before 1957 is usually treated as presumptive evidence, health-care workers face more frequent exposure to people with measles and may also expose patients who are especially vulnerable. Their occupational setting changes the risk calculation.
Adults vaccinated from 1963 through 1967 may also need to review their history. Some children received an inactivated, or killed-virus, measles vaccine during those years. It was less effective than the live, weakened-virus vaccine used in current MMR shots. People who know they received the inactivated vaccine, or are unsure whether they did, should receive at least one dose of the live MMR vaccine, according to doctors quoted in the article.

The history of U.S. recommendations is another reason records can matter. Until 1989, a single dose was the standard schedule. The current advice described in the report calls for at least one documented dose for adults, while two doses are recommended for certain high-risk groups that lack other evidence of immunity.
Why the guidance is targeted
A targeted approach reflects two realities at once. First, vaccination is highly effective and protection usually endures. Second, measles spreads efficiently when it reaches communities with gaps in protection. The current outbreaks show that elimination status is not permanent if transmission becomes sustained.
People who know they have had measles or have documented, appropriate MMR vaccination generally have a clear answer: another dose is usually unnecessary. The more difficult cases are people without records, people vaccinated in the 1963–67 period, and people whose jobs create unusually high exposure risk. For those groups, discussing their history with a clinician can help determine whether an MMR dose is appropriate.
The immediate public-health message remains straightforward: people with no documented vaccination and no other evidence of immunity should not assume they are protected. Ensuring that people have the recommended MMR coverage is the most effective step described in the report for limiting measles transmission as outbreaks continue.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com







